New developments in Brugada Syndrome
Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest.
Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations.
Efficacy of quinidine in high-risk patients with Brugada syndrome.
Hydroquinidine therapy in Brugada syndrome.
Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes.
